Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale.

Saved in:
Bibliographic Details
Title: Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale.
Authors: Nery PB; Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Canada.. Electronic address: PNery@ottawaheart.ca., Wells GA; Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Canada.; Cardiovascular Research Methods Center, University of Ottawa Heart Institute, Ottawa, Canada., Verma A; McGill University Health Center, Montreal, Quebec, Canada., Joza J; McGill University Health Center, Montreal, Quebec, Canada., Nair GM; Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Canada., Veenhuyzen G; Libin Cardiovascular Institute, University of Calgary, Calgary, Canada., Andrade J; Vancouver General Hospital, University of British Columbia,Vancouver, Canada., Nault I; Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ), Quebec City, Quebec, Canada., Wong JA; Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada., Sikkel M; Victoria Cardiac Arrhythmia Trials, Victoria, British Columbia, Canada., Essebag V; McGill University Health Center, Montreal, Quebec, Canada; Hôpital Sacré-Cœur, Université de Montréal, Montréal, Québec, Canada., Macle L; Montreal Heart Institute, Montreal, Québec, Canada., Sapp J; Queen Elizabeth II Health Sciences, Halifax, Nova Scotia, Canada., Roux JF; CHUS-Sherbrooke, Sherbrooke, Quebec, Canada., Skanes A; Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada., Angaran P; St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada., Novak P; Victoria Cardiac Arrhythmia Trials, Victoria, British Columbia, Canada., Redfearn D; Kingston General Hospital, Kingston, Ontario, Canada., Golian M; Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Canada., Redpath CJ; Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Canada., Sturmer M; Hôpital Sacré-Cœur, Université de Montréal, Montréal, Québec, Canada., Birnie D; Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Canada.
Source: American heart journal [Am Heart J] 2022 Dec; Vol. 254, pp. 133-140. Date of Electronic Publication: 2022 Aug 27.
Publication Type: Journal Article; Clinical Trial Protocol
Journal Info: Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6744 (Electronic) Linking ISSN: 00028703 NLM ISO Abbreviation: Am Heart J Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1097-6744
DOI:10.1016/j.ahj.2022.08.010